Literature DB >> 30575237

Exploring the role of motivational interviewing in adolescent patient-provider communication about type 1 diabetes.

Laura J Caccavale1, Rosalie Corona2, Jessica G LaRose3, Suzanne E Mazzeo2, Alexandra R Sova3, Melanie K Bean1.   

Abstract

OBJECTIVE: Adolescents with type 1 diabetes (T1D) frequently experience deterioration in glycemic control. Providers have unique opportunities to address diabetes self-management, yet little is known about the most effective way to communicate with adolescents. This investigation used a motivational interviewing (MI) framework to characterize naturally-occurring adolescent patient-provider communication in medical encounters and examined relations between adolescent patient-provider communication and (a) T1D self-management and (b) glycemic control (hemoglobin A1c [HbA1c]).
METHODS: Medical encounters between pediatric endocrine providers and 55 adolescents with T1D (49% female; M age = 14.8 years; M baseline HbA1c = 8.6%) were audio recorded and coded using standardized rating instruments. Patients and parents completed measures assessing T1D care behaviors and self-efficacy. Assessments were completed at routine endocrinology visits (baseline) and 1 and 3-month post-baseline; HbA1c was obtained from medical records at baseline and 3-month.
RESULTS: Hierarchical multiple regressions showed that greater provider use of MI non-adherent behaviors (eg, confronting, persuading) was associated with (a) poorer 3-month HbA1c, P < 0.001; (b) worse 1-month adolescent diabetes adherence P < 0.001, and (c) lower diabetes self-efficacy at 1-month (P < 0.001) follow-up. Lower patient self-efficacy for diabetes self-management mediated the relation between provider use of MI non-adherent language and lower diabetes adherence (P = 0.020).
CONCLUSION: Providers' use of persuasion and confrontation regarding risks of non-adherence was associated with poorer glycemic control and adherence. Communication training for providers that targets reductions in MI-inconsistent language may have the potential to improve diabetes self-care in this vulnerable population.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adolescents; communication; motivational interviewing; type 1 diabetes

Mesh:

Substances:

Year:  2019        PMID: 30575237      PMCID: PMC7196323          DOI: 10.1111/pedi.12810

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  4 in total

1.  Engagement and Affective Communication During Pediatric Nephrology Clinic Visits: Associations with Medication Adherence.

Authors:  Trevor W Glenn; Kristin A Riekert; Debra Roter; Michelle N Eakin; Cozumel S Pruette; Tammy M Brady; Susan R Mendley; Shamir Tuchman; Barbara A Fivush; Cyd K Eaton
Journal:  Patient Educ Couns       Date:  2020-09-05

2.  Global Well-Being Is Associated With A1C and Frequency of Self-Monitoring of Blood Glucose in Predominately Latinx Youth and Young Adults With Type 1 Diabetes.

Authors:  Ananta Addala; Randall Y Chan; Jaclyn Vargas; Marc J Weigensberg
Journal:  Diabetes Spectr       Date:  2021-12-21

3.  Motivational Interviewing and Glycemic Control in Adolescents With Poorly Controlled Type 1 Diabetes: A Randomized Controlled Pilot Trial.

Authors:  Anna-Kaisa Tuomaala; Matti Hero; Martti T Tuomisto; Maria Lähteenmäki; Päivi J Miettinen; Tiina Laine; Karoliina Wehkalampi; Sanne Kiiveri; Pekka Ahonen; Marja Ojaniemi; Kari Kaunisto; Päivi Tossavainen; Risto Lapatto; Taisto Sarkola; Mari-Anne Pulkkinen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

4.  Efficacy of Motivational Interviewing to Improve Utilization of Mental Health Services Among Youths With Chronic Medical Conditions: A Cluster Randomized Clinical Trial.

Authors:  Christina Reinauer; Anna Lena Platzbecker; Rabea Viermann; Matthias Domhardt; Harald Baumeister; Katharina Foertsch; Hannah Linderskamp; Lisa Krassuski; Doris Staab; Kirsten Minden; Reinhold Kilian; Reinhard W Holl; Petra Warschburger; Thomas Meißner
Journal:  JAMA Netw Open       Date:  2021-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.